A patient with a germline GATA2 mutation and primary myelofibrosis
- PMID: 33560389
- PMCID: PMC7876883
- DOI: 10.1182/bloodadvances.2020003401
A patient with a germline GATA2 mutation and primary myelofibrosis
Abstract
First description of a patient with a germline GATA2 mutation and diagnosis of primary myelofibrosis.
Development of bone marrow failure on a Janus kinase inhibitor.
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Figures


References
-
- Wieser R, Volz A, Vinatzer U, et al. . Transcription factor GATA-2 gene is located near 3q21 breakpoints in myeloid leukemia. Biochem Biophys Res Commun. 2000;273(1):239-245. - PubMed
-
- Kitajima K, Tanaka M, Zheng J, et al. . Redirecting differentiation of hematopoietic progenitors by a transcription factor, GATA-2. Blood. 2006;107(5):1857-1863. - PubMed
-
- Pevny L, Simon MC, Robertson E, et al. . Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 1991;349(6306):257-260. - PubMed
-
- Weiss MJ, Keller G, Orkin SH. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes Dev. 1994;8(10):1184-1197. - PubMed
-
- Pevny L, Lin CS, D’Agati V, Simon MC, Orkin SH, Costantini F. Development of hematopoietic cells lacking transcription factor GATA-1. Development. 1995;121(1):163-172. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources